INO
Inovio Pharmaceuticals
$0.93
+$0.04 (+4.38%)Oct 28, 2026
Key metrics
The numbers that frame INO today
- Market cap
- $96.06M
- ROIC
- 528.6%
- Div yield
- 0%
- Debt / equity
- 1.8
- 52wk Low
- $0.57
- 52wk High
- $2.72
Growth
Revenue and earnings trend for INO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about INO
Is Inovio Pharmaceuticals a good buy?
No. Inovio Pharmaceuticals has poor quality and mixed momentum. The setup is weak overall. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Inovio Pharmaceuticals is selling at a very high price.
What is the market capitalization of INO?
Inovio Pharmaceuticals's market capitalization is $96.06M.
What is the 52-week high for INO stock?
The 52-week high for Inovio Pharmaceuticals is $2.72. The current close of $0.93 is 65.8% below that high.
What is the 52-week low for INO stock?
The 52-week low for Inovio Pharmaceuticals is $0.57. The current close of $0.93 is 63.8% above that low.
Does INO stock pay dividends?
Inovio Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for INO?
Inovio Pharmaceuticals's Debt / Equity ratio is 1.83.